However, major amplification of MLK4 was identified in patients with triple-negative breast invasive carcinoma and the lack of targeted therapies in TNBC prompt us to investigate the role of MLK4 in this specific subtype of breast cancer. This evidence concerns the gene MAP3K21 and breast carcinoma.